Idiopathic nephrotic syndrome: the EBV hypothesis

Area of Science:

• Nephrology
• Virology
• Immunology

Background:

• Steroid-sensitive nephrotic syndrome (SSNS) is characterized by massive proteinuria and podocyte injury.
• The underlying mechanisms of SSNS are not fully understood, but a role for Epstein-Barr Virus (EBV) is increasingly suggested.
• EBV infection and specific antibody responses are observed in SSNS patients.

Purpose of the Study:

• To investigate the potential role of Epstein-Barr Virus (EBV) and associated antibodies in the pathogenesis of steroid-sensitive nephrotic syndrome (SSNS).
• To explore the mechanism by which EBV might induce podocyte damage and proteinuria in SSNS.

Main Methods:

• Analysis of EBV replication and antibody responses (anti-EBNA1) in SSNS patients.
• Investigation of memory B cell phenotypes and their reconstitution post-rituximab therapy.
• Hypothesizing a mechanism involving anti-EBNA1 antibody cross-reactivity with podocyte proteins via the neonatal Fc receptor.

Main Results:

• EBV replication is detected in 50% of patients during the initial disease flare.
• Genetic factors in SSNS influence antibodies against EBNA1.
• Memory B cell reconstitution after rituximab predicts proteinuria relapse.

Conclusions:

• A proposed mechanism suggests anti-EBNA1 antibodies, internalized by podocytes, cross-react with a key podocyte protein, leading to its depletion and subsequent podocyte damage.
• This damage results in foot process effacement and massive proteinuria.
• B cell immunosuppression and antibody clearance may restore protein levels, improving proteinuria and podocyte morphology.